Vein Wall Invasion Is a More Reliable Predictor of Oncological Outcomes than Vein-Related Margins after Pancreaticoduodenectomy for Early Stages of Pancreatic Ductal Adenocarcinoma.

local recurrence pancreatic ductal adenocarcinoma pancreatoduodenectomy portomesenteric vein groove survival vein resection vein wall invasion

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
17 Nov 2023
Historique:
received: 09 10 2023
revised: 11 11 2023
accepted: 14 11 2023
medline: 24 11 2023
pubmed: 24 11 2023
entrez: 24 11 2023
Statut: epublish

Résumé

Pancreaticoduodenectomy (PD) with vein resection is the only potentially curative option for patients with pancreatic ductal adenocarcinoma (PDAC) with venous involvement. The aim of our study was to assess the oncological prognostic significance of the different variables of venous involvement in patients undergoing PD for resectable and borderline-resectable with venous-only involvement (BR-V) PDAC. We performed a retrospective analysis of prospectively acquired data over a 10-year period. Of the 372 patients included, 105 (28%) required vein resection and vein wall involvement was identified in 37% of those. A multivariable analysis failed to identify the vein-related resection margins as independent predictors for OS, DFS or LR. Vein wall tumour involvement was an independent predictor of OS (risk x1.7-2) and DFS (risk x1.9-2.2) in all models, while it replaced overall surgical margin positivity as the only parameter independently predicting LR during an analysis of separate resection margins (risk x2.4). Vein wall tumour invasion may be a more reliable predictor of oncological outcomes compared to traditionally reported parameters. Future studies should focus on possible pre-operative investigations that could identify these cases and management pathways that could yield a survival benefit, such as the use of neoadjuvant treatments.

Identifiants

pubmed: 37998601
pii: diagnostics13223465
doi: 10.3390/diagnostics13223465
pmc: PMC10670022
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Ann Surg. 1977 Jul;186(1):42-50
pubmed: 195543
HPB (Oxford). 2017 Aug;19(8):713-720
pubmed: 28566239
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Br J Surg. 2015 Nov;102(12):1459-72
pubmed: 26350029
Am J Surg. 2003 Aug;186(2):149-53
pubmed: 12885608
Cancer. 2012 Aug 1;118(15):3801-11
pubmed: 22180096
Surgery. 2014 Jun;155(6):977-88
pubmed: 24856119
Ann Surg Oncol. 2021 Aug;28(8):4592-4601
pubmed: 33393047
Br J Surg. 2016 Nov;103(12):1683-1694
pubmed: 27686238
Ann Surg. 2020 Nov;272(5):731-737
pubmed: 32889866
Pancreas. 2020 Nov/Dec;49(10):1264-1275
pubmed: 33122513
Pancreas. 2020 Apr;49(4):e31-e33
pubmed: 32282777
Asian J Surg. 2021 Jan;44(1):313-320
pubmed: 32972828
Ann Surg. 2008 Feb;247(2):300-9
pubmed: 18216537
Histopathology. 2009 Sep;55(3):277-83
pubmed: 19723142
Ann Surg Oncol. 2018 Apr;25(4):845-847
pubmed: 28752469
Ann Surg Oncol. 2018 Jun;25(6):1760-1767
pubmed: 29651577
Ann Surg. 2009 Jul;250(1):76-80
pubmed: 19561479
Am J Surg. 2013 May;205(5):613-7; discussion 617
pubmed: 23592172
PLoS One. 2021 Mar 18;16(3):e0248633
pubmed: 33735191
Histopathology. 2011 Dec;59(6):1111-21
pubmed: 22175891
Pancreatology. 2017 Sep - Oct;17(5):847-857
pubmed: 28843714
HPB (Oxford). 2020 Jan;22(1):50-57
pubmed: 31186199
HPB (Oxford). 2016 Apr;18(4):305-11
pubmed: 27037198
HPB (Oxford). 2020 Sep;22(9):1240-1249
pubmed: 32046922
Ann Surg. 2009 Jul;250(1):81-7
pubmed: 19561478
Eur J Surg Oncol. 2017 Feb;43(2):358-363
pubmed: 27856064
Br J Surg. 2021 Dec 17;109(1):96-104
pubmed: 34791069
J Gastrointest Surg. 2009 Apr;13(4):784-92
pubmed: 19137380
JAMA Surg. 2019 Nov 1;154(11):1038-1048
pubmed: 31483448
J Gastrointest Surg. 2004 Dec;8(8):935-49; discussion 949-50
pubmed: 15585381
Histopathology. 2021 Dec;79(6):902-912
pubmed: 34379823
Ann Surg. 2008 Jul;248(1):97-103
pubmed: 18580212
J Gastrointest Surg. 2017 Jan;21(1):164-174
pubmed: 27778257
World J Surg. 2012 Apr;36(4):884-91
pubmed: 22350478
Arch Surg. 2007 Feb;142(2):172-9; discussion 180
pubmed: 17309969
Br J Surg. 2017 Oct;104(11):1539-1548
pubmed: 28833055
Br J Surg. 2016 Feb;103(3):179-91
pubmed: 26663252
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
JAMA Surg. 2013 Apr;148(4):331-8
pubmed: 23715922
Ann Surg. 2016 Sep;264(3):457-63
pubmed: 27355262
Ann Surg. 2015 Sep;262(3):486-94; discussion 492-4
pubmed: 26258317
Surgery. 2021 Mar;169(3):649-654
pubmed: 32807504
Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):349-64
pubmed: 16549332
Ann Surg Oncol. 2008 Jun;15(6):1651-60
pubmed: 18351300
J Natl Compr Canc Netw. 2014 Aug;12(8):1083-93
pubmed: 25099441
Lancet Oncol. 2013 Oct;14(11):e476-e485
pubmed: 24079875
Ann Surg. 2017 Mar;265(3):565-573
pubmed: 27918310
Surgery. 2018 May;163(5):1053-1062
pubmed: 29331400

Auteurs

Manish Ahuja (M)

Department of HPB and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

Rupaly Pandé (R)

Department of HPB and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

Shafiq Chugtai (S)

Department of HPB and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

Rachel M Brown (RM)

Department of Pathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

Owen Cain (O)

Department of Pathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

David C Bartlett (DC)

Department of HPB and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

Bobby V M Dasari (BVM)

Department of HPB and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

Ravi Marudanayagam (R)

Department of HPB and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

Keith J Roberts (KJ)

Department of HPB and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2SQ, UK.

John Isaac (J)

Department of HPB and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

Robert P Sutcliffe (RP)

Department of HPB and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

Nikolaos Chatzizacharias (N)

Department of HPB and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

Classifications MeSH